Temperature screening has become a common Covid mitigation practice in many settings. But as noted by one of our Healthcare Triage viewers, this practice doesn’t seem that effective at face value. So should we be relying on temperature checks to help curb the spread of Covid-19, or is it just medical theater that distracts from more useful efforts?
Experts have long been calling for quicker, cheaper, and more accessible ways of testing for Covid-19. Though such tests would be less accurate than the predominant PCR test, speed matters more than accuracy when it comes to curbing a pandemic. The FDA just issued an Emergency Use Authorization for a fairly affordable, at-home Covid test that renders results in 15 minutes, providing a useful mitigation resource as vaccine distribution rolls out.
We recently spoke with Dr. Kate O’Brien, director of the Department of Immunization, Vaccines and Biologicals at the World Health Organization. We spoke with Dr. O’Brien about how the Covid vaccine works, safety questions and concerns, and issues of distribution – including how we plan to distribute it equitably.
We’re getting close to a year of living with Covid-19, but work is still ongoing to understand the mechanisms behind some of its most devastating effects. A lot of attention has been given to Cytokine Storms in this realm, but with some conflicting evidence there, Bradykinin Storms are starting to share some of the spotlight.
One argument we continue to hear about the reaction to Covid-19 is that “it’s just another flu”, and that we can move forward with life as usual, much like we move forward with life during flu season. While we wish that were true, it simply is not. There are major differences that necessitate a much bigger reaction to Covid-19. In today’s episode we detail both the similarities and the differences between the illnesses caused by these two viruses.
Ah, Vitamin D, back again. We’ve made our case on how unnecessary Vitamin D supplements are for outcomes like diabetes, cardiovascular and musculoskeletal health, and overall mortality. But what about its effect on viral infections like Covid-19? Can it reduce symptom severity, or perhaps even reduce your odds of becoming infected in the first place?
Aaron Carroll talks with Dr. Bruce Lamb and Dr. Alan Palkowitz about Alzheimer’s disease. They discuss how they’re combining their different backgrounds and strengths – basic science in university research for Lamb and drug discovery in the pharmaceutical industry for Palkowitz – as they work to develop potential treatments for Alzheimer’s disease.
This episode of the Healthcare Triage podcast is sponsored by Indiana University School of Medicine whose mission is to advance health in the state of Indiana and beyond by promoting innovation and excellence in education, research and patient care.
IU School of Medicine is leading Indiana University’s first grand challenge, the Precision Health Initiative, with bold goals to cure multiple myeloma, triple negative breast cancer and childhood sarcoma and prevent type 2 diabetes and Alzheimer’s disease.
Available where you get your podcasts! Including iTunes
Does the world’s most common pain relief drug do more than just reduce pain? Recent headlines would have you believe that it also reduces your perception of risk, resulting in more risk-taking behaviors. We think it’s time to take a closer look at the details before deciding to ditch the Tylenol.
The president recently signed an executive order on a handful of health care issues. Among other things, it points to protections for those with preexisting conditions. But does it do anything more than point at them? What exactly does it mean for those who have been waiting patiently for a promised healthcare plan to potentially replace the Affordable Care Act?
The federal response to the Covid-19 pandemic has been criticized as somewhat…disorganized. Joe Biden and Kamala Harris have outlined a plan for how their administration would approach the pandemic, should they be elected to the White House. Today we’re laying out all the points in their proposal.
Austin and Aaron are participants in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazon.com.